Phase I pharmacological study of continuous chronomodulated capecitabine treatment.
Roosendaal J, Jacobs BAW, Pluim D, Rosing H, de Vries N, van Werkhoven E, Nuijen B, Beijnen JH, Huitema ADR, Schellens JHM, Marchetti S.
Roosendaal J, et al.
Pharm Res. 2020 May 7;37(5):89. doi: 10.1007/s11095-020-02828-6.
Pharm Res. 2020.
PMID: 32382808
Free PMC article.
Clinical Trial.